Oncology in the Time of COVID

The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.

Ipsos white paper - Oncology in the Time of COVID: Assessing the impact of the COVID-19 pandemic on the indian oncology marketCancer patients in particular experienced impacts to many aspects of their care – two years on we reflect on specific effects seen in the Indian oncology market and how we believe a promising new upturn is taking shape.

In this paper, we combine data from three Ipsos studies conducted in India with our current therapy expertise and market insight, to outline how the COVID-19 pandemic influenced drug-treated cancer patient estimates, oncology drug revenue estimates and patient caseload management.

We also offer a forward-looking perspective on how we believe new healthcare initiatives put in place in this region may alleviate the effects of the pandemic and the future cancer treatment landscape.

Download

More insights about Health

Related news

  • [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?
    Society Webinar

    [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?

    At our next KEYS webinar, we’ll be sharing on-the-ground perspectives as people give us their in-the-moment takes on how they see their lives - and their status in life - these days. Along the way we’ll hear about freedom (in the US), familismo (in Mexico) and understatedness (in the UK).
  • [Webinar] KEYS: Global Trends - The Uneasy Decade
    Global Trends Events replay

    [Webinar] KEYS: Global Trends - The Uneasy Decade

    At the next episode of our KEYS webinar, the Ipsos Global Trends team will be launching the findings of our latest report. This 9th edition explores how the trends that will shape the future are evolving, as the uneasy decade continues.
  • [Webinar] KEYS: Uncharted Territory
    Economy Events replay

    [Webinar] KEYS: Uncharted Territory

    The next episode of our KEYS webinar series is dedicated to what we’ve learned so far during 2025. Are we adapting fast enough? And are there areas where we need to change course?